Catalyst
Slingshot members are tracking this event:
BlueBird Bio's (BLUE) LentiGlobin for Transfusion-Dependent Beta Thalassemia Granted PRIME Status by EMA
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| BLUE |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 21, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Transfusion-dependent, Beta-thalassemia, European Medicines Agency, Prime Program
